Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ALNY
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Alnylam Pharmaceuticals (ALNY) trades at $219.89, up 0.08% on the day, with a bearish technical signal from moving averages but a neutral oscillator stance. The company shows strong fundamental improvement, with 2025 revenue reaching $3.71 billion and net income turning positive at $313.75 million, marking a significant shift from prior losses. Recent news includes a securities fraud investigation announcement and continued product momentum for AMVUTTRA.
The outlook is mixed; analyst consensus is strongly bullish with a $347.33 price target, but technical weakness and legal overhangs present near-term risks. Long-term growth prospects in RNAi therapeutics and robust profitability metrics support upside potential, though execution on clinical trials and competitive dynamics remain key watchpoints for investors.
Read full analysis

Key Stats

  • Market Cap
    $29.97B
  • Volume
    1,356,361
  • Sector
    Health
  • 52W High
    $491.22
  • 52W Low
    $205.48
  • Typical Hold Time
    41 Days
  • Enterprise Value
    $27.92B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$226
52W Low: $205.48
30 Jul 2026
52W High: $491.22
20 Oct 2025

Track Alnylam Pharmaceuticals, Inc. (ALNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $205.48 and a high of $491.22, highlighting its annual price range. Buy and sell Alnylam Pharmaceuticals, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Most Recent News

Content is generated by Aura AI

Titan Mining's subsidiary signs deal to build graphite plant for US Army in Alabama.

Titan Mining's subsidiary, Empire State Mines, has signed a preliminary agreement with the US Army to develop a graphite processing facility at Anniston Army Depot, Alabama. The plant will produce purified micronized graphite for defense and industri...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Titan Mining's subsidiary signs deal to build graphite plant for US Army in Alabama.

Meta and Sierra launch a protocol for AI agents to interact directly with businesses securely.

Meta Platforms and Sierra have introduced the Personal Agent Protocol, an open standard allowing personal AI agents to interact directly with businesses. This protocol aims to streamline AI-driven customer interactions by enabling agents to connect t...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Meta and Sierra launch a protocol for AI agents to interact directly with businesses securely.

McDonald's sued for alleged AI-driven price-fixing among franchisees raising menu prices

McDonald's faces a federal class-action lawsuit accusing its AI pricing tool of coordinating prices among franchisees, leading to higher menu costs. The suit claims McDonald's shares nonpublic sales data and uses it to generate price recommendations ...

Market News
4 hours ago
Proactive Investors
Bearish
news icon
McDonald's sued for alleged AI-driven price-fixing among franchisees raising menu prices
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $29.97B
  • Volume
    1,356,361
  • Sector
    Health
  • 52W High
    $491.22
  • 52W Low
    $205.48
  • Typical Hold Time
    41 Days
  • Enterprise Value
    $27.92B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$226
52W Low: $205.48
30 Jul 2026
52W High: $491.22
20 Oct 2025

Track Alnylam Pharmaceuticals, Inc. (ALNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $205.48 and a high of $491.22, highlighting its annual price range. Buy and sell Alnylam Pharmaceuticals, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!